Systems and method for detecting cognitive impairment

Patent metadata

Field	Value
Publication number	US-11963786-B2
Application number	US-201917298925-A
Country	US
Kind code	B2
Filing date	Dec 6, 2019
Priority date	Dec 7, 2018
Publication date	Apr 23, 2024
Grant date	Apr 23, 2024

Abstract

Systems, methods, and computer readable media for determining cognitive impairment (CI) in patients are provided herein. Various regional structural-functional parameters of the retina can serve as biomarkers for the detection of CI. The method can include forming a database including a quantification of retinal structure and retinal function of a plurality of eyes associated with a plurality of patients, providing a baseline cognitive impairment (CI) reference. The method can include determining a measure of functionality of neurons in the retina based on an electroretinogram (ERG) of a patient. The method can include determining a structural measure of the first retina based on a generalized dimension spectrum and singularity spectrum of the skeletonized retinal image, and a lacunarity parameter of the skeletonized retinal image. The method can include determining a level of cognitive impairment based on the structural and functional measures.

First claim

What is claimed is:

1. A method for determining cognitive impairment (CI) implemented by at least one processor, the method comprising:
forming a database including a quantification of retinal structure and retinal function of a plurality of eyes associated with a plurality of patients, the quantification providing a baseline cognitive impairment (CI) reference;
receiving an electroretinogram (ERG) of a retina of a patient;
determining a measure of functionality of neurons in the retina based on the ERG;
receiving a retinal image of the retina;
skeletonizing the retinal image as a skeletonized retinal image;
determining a structural measure of the first retina based on
a generalized dimension spectrum and singularity spectrum of the skeletonized retinal image, and
a lacunarity parameter of the skeletonized retinal image;

comparing the measure of functionality and the structural measure of the retina to the database; and
determining a level of cognitive impairment of the patient based on the comparing.

2. The method of claim 1 , further comprising updating the database with the measure of functionality and the structural measure of the retina.

3. The method of claim 1 , further comprising:
subdividing the skeletonized retinal image into multiple subregions; and
determining a structural measure of the each subregion of the multiple subregions based on
a generalized dimension spectrum and singularity spectrum of each subregion, and
a lacunarity parameter of each subregion.

4. The method of claim 1 , wherein the retinal image comprises an image of an entire branching pattern of the retina observable in a 20°-200° field of view.

5. The method of claim 1 , wherein the quantification of the retinal function comprises a plurality of ERGs associated with patients known to have a level of CI.

6. The method of claim 1 , wherein the quantification of the retinal structure comprises a plurality of generalized dimension spectrum and a singularity spectrum associated with retinal images associated within patients known to have a level of CI.

7. The method of claim 1 , wherein the database further includes the caliber, asymmetry factor, tortuosity, and network complexity of the retinal microvasculature (arteries and veins) with respect to functional features (e.g., contrast sensitivity, electrical response through ERGs), concomitant with both fractal-vascular and neural analysis.

8. The method of claim 1 , wherein lacunarity (A) comprises a measure of coarseness of the skeletonized retinal image.

9. A system for determining cognitive impairment (CI) comprising:
a database including a quantification of retinal structure and retinal function of a plurality of eyes associated with a plurality of patients, the quantification providing a baseline cognitive impairment (CI) reference; and
at least one processor configured to
receive an electroretinogram (ERG) of a retina of a patient,
determine a measure of functionality of neurons in the retina based on the ERG,
receive a retinal image of the retina,
skeletonize the retinal image as a skeletonized retinal image,
determine a structural measure of the first retina based on
a generalized dimension spectrum and singularity spectrum of the skeletonized retinal image, and
a lacunarity parameter of the skeletonized retinal image,

compare the measure of functionality and the structural measure of the retina to the database, and
determine a level of cognitive impairment of the patient based on the comparing.

10. The system of claim 9 , wherein the one or more processors are further configured to update the database with the measure of functionality and the structural measure of the retina.

11. The system of claim 9 , wherein the one or more processors are further configured to:
subdivide the skeletonized retinal image into multiple subregions; and
determine a structural measure of the each subregion of the multiple subregions based on
a generalized dimension spectrum and singularity spectrum of each subregion, and
a lacunarity parameter of each subregion.

12. The system of claim 9 , wherein the retinal image comprises an image of an entire branching pattern of the retina observable in a 20°-200° field of view.

13. The system of claim 9 , wherein the quantification of the retinal function comprises a plurality of ERGs associated with patients known to have a level of CI.

14. The system of claim 9 , wherein the quantification of the retinal structure comprises a plurality of generalized dimension spectrum and a singularity spectrum associated with retinal images associated within patients known to have a level of CI.

15. The system of claim 9 , wherein the database further includes the caliber, asymmetry factor, tortuosity, and network complexity of the retinal microvasculature (arteries and veins) with respect to functional features (e.g., contrast sensitivity, electrical response through ERGs), concomitant with both fractal- vascular and neural analysis.

16. The system of claim 9 , wherein lacunarity (A) comprises a measure of coarseness of the skeletonized retinal image.

17. A non-transitory computer-readable medium storing instructions that when executed by one or more processors, cause the one or more processors to:
form a database including a quantification of retinal structure and retinal function of a plurality of eyes associated with a plurality of patients, the quantification providing a baseline cognitive impairment (CI) reference;
receive an electroretinogram (ERG) of a retina of a patient;
determine a measure of functionality of neurons in the retina based on the ERG;
receiving a retinal image of the retina;
skeletonize the retinal image as a skeletonized retinal image;
determine a structural measure of the first retina based on
a generalized dimension spectrum and singularity spectrum of the skeletonized retinal image, and
a lacunarity parameter of the skeletonized retinal image;

comparing the measure of functionality and the structural measure of the retina to the database; and
determine a level of cognitive impairment of the patient based on the comparing.

18. The non-transitory computer-readable medium of claim 17 , further comprising instructions that cause the one or more processors to update the database with the measure of functionality and the structural measure of the retina.

19. The non-transitory computer-readable medium of claim 17 , further comprising instructions that cause the one or more processors to update:
subdivide the skeletonized retinal image into multiple subregions; and
determine a structural measure of the each subregion of the multiple subregions based on
a generalized dimension spectrum and singularity spectrum of each subregion, and
a lacunarity parameter of each subregion.

20. The non-transitory computer-readable medium of claim 17 , wherein the retinal image comprises an image of an entire branching pattern of the retina observable in a 20°-200° field of view.

Assignees

• Univ Miami

Inventors

• Debuc Delia

Classifications

• A61B5/4088 Primary

  Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia · CPC title

• A61B3/12

  for looking at the eye fundus, e.g. ophthalmoscopes (A61B3/13 takes precedence) · CPC title

• A61B5/398

  Electrooculography [EOG], e.g. detecting nystagmus; Electroretinography [ERG] · CPC title

• A61B5/4842

  Monitoring progression or stage of a disease · CPC title

• A61B5/489

  Blood vessels · CPC title